Subscribe
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
TESTIMONY
Remarks to the European Parliament on EFSD/ EFSD+
September 24, 2025
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
CGD NOTE
March 14, 2022
In the face of sudden economic shocks and natural disasters that limit the ability of economies to rapidly raise revenue, MDBs have the potential to play a leading role in crisis response to minimize the damage. One key factor in their success in this role is the speed of their financing instruments...
WORKING PAPER
March 14, 2022
Following the outbreak and spread of COVID-19 in 2020, schools around the world closed for significant periods of time. Many scholars provided projections of the likely impacts on educational outcomes, with potentially dire impacts on learning loss and—especially in low-income contexts–dropout rates...
CGD NOTE
March 08, 2022
Governments have implemented an array of interventions needed to contain the economic impacts of COVID-19. Some of these interventions are not adequately captured in traditional fiscal metrics, such as debt and deficit. One approach to ensuring comprehensive coverage of these interventions and to pr...
POLICY PAPER
March 04, 2022
The East Asian export-led development model has served as a beacon for decades. For the many urbanized and rapidly urbanizing countries, the East Asian experience with and response to emerging challenges can be equally instructive. High-income East Asian economies are at or approaching peak urbaniza...
CGD NOTE
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...
CGD NOTE
March 03, 2022
Corrective taxes on harmful products—health taxes—are a cost-effective way to save lives and generate additional tax revenue. In new research, we show that health tax measures during COVID-19 have diminished in number and strength because the international community has mobilized additional, largely...
CGD NOTE
February 24, 2022
The worldwide shock inflicted by COVID-19 had the making of a “perfect crisis:” the kind that should not be wasted. Indeed, it could serve as an opportunity to initiate major reforms. Unfortunately, Pakistan, like virtually all other countries, has permitted the opportunity to go waste. Pakistan may...
